MEGGA MIX
MEGGA MIX: Physician-Supervised Medical Food Supporting Gut Health During Antibiotic Therapy
Targeted Nutritional Support for Vulnerable Gut Defense
Intended Use
MEGGA MIX is a food-derived oral antibody product for nutritional management of impaired gut pathogen defense associated with antibiotic-induced microbiome disruption.
It is intended for use under medical supervision in hospitals, long-term care facilities, and other clinically supervised settings.
Mechanism of Action
Provides targeted egg-derived IgY antibodies that act locally in the gastrointestinal tract
Supports gut defense mechanisms that can be compromised by antibiotic therapy
Non-systemic, luminal activity only; does not alter host immunity or replace antibiotics
Nutritional Role
Supplies dietary IgY antibodies, a naturally occurring food component derived from eggs
Designed to support pathogen-binding capacity during periods of microbiome vulnerability
Physician-supervised administration allows integration with ongoing antibiotic therapy
Medical Food Justification
MEGGA MIX meets U.S. Medical Food criteria:
- Addresses a disease-associated nutritional requirement
- Formulated specifically for dietary management of that requirement
- Intended for use under physician supervision
- Provides functionality not achievable through normal diet alone
- Acts via nutritional, not pharmacologic, means
Hospital Protocol Integration
Compatible with all antibiotic regimens; no systemic absorption
Can be ordered via nutrition services alongside enteral nutrition
Supports antimicrobial stewardship goals by promoting gut microbial balance
Low per-patient cost relative to downstream complications (illustrative projections)
Economic & Operational Advantages
Proposed Use Protocol
Initiate with high-risk antibiotic therapy
Continue through the course of antibiotics plus recovery period
Discontinue once microbial balance is restored or as clinically indicated
Strategic Summary
MEGGA MIX represents a new category of medical nutrition: targeted, pathogen-specific dietary antibodies designed to support gut microbial defense during periods of antibiotic-induced vulnerability.
